Clinical Trial Detail

NCT ID NCT03082300
Title A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications

lung non-small cell carcinoma

Therapies

Naquotinib

Age Groups: adult senior

No variant requirements are available.